CLL patients exhibited elevated TFPI levels (median: 16.9 ng/mL, range: 8.5–27.2 ng/mL) as compared to healthy controls (median: 10.8 ng/mL, range: 5.7–21.4 ng/mL; Fig. 1). Here, TFPI is linked to B-cell chronic lymphocytic leukemia.